Tobacco Use Disorder
📧 Sign up to get email alerts when something new happens for Tobacco Use Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: Nicotine Patch Pretreatment for Smoking Cessation in PTSD [EARLY_Phase 1]
This early-phase trial tested whether pretreating individuals with posttraumatic stress disorder who smoke with a nicotine patch improves sm…
-
CLINICAL_TRIALS research · 2014-11-19Clinical Trial Update: QuitAdvisorMD: A Point-of-care Tool for Brief Smoking Cessation Interventions [Phase 2]
Phase 2 clinical trial update for QuitAdvisorMD, a point-of-care tool for brief smoking cessation interventions (status unknown).
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Clinical Study of Smoke-Break Liquid Cigarettes [Phase 2]
A Phase 2 clinical study evaluating Smoke-Break Liquid Cigarettes by Smoke-Break, Inc. has completed.
-
CLINICAL_TRIALS trial_result · 2014-11-18Clinical Trial Update: Tobacco Tactics Website for Operating Engineers [Phase 3]
Phase 3 clinical trial evaluating the Tobacco Tactics website for tobacco use cessation among operating engineers has completed.
-
CLINICAL_TRIALS research · 2014-11-18Clinical Trial Update: Effect of Self-administered Auricular Acupressure on Smoking Cessation-a Pilot Study [Phase 2]
Phase 2 pilot study evaluating self-administered auricular acupressure for smoking cessation; current status is unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-11-03FDA Approved: FOSTER AND THRIVE NICOTINE — Supplemental Application (Strategic Sourcing Services LLC)
FDA approved a supplemental application for Foster and Thrive Nicotine (nicotine polacrilex), a nicotine replacement therapy for smoking ces…
-
FDA approval · 2014-10-30FDA Approved: NICORETTE ORIGINAL — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NICORETTE ORIGINAL (nicotine polacrilex) from Haleon US Holdings LLC.
-
FDA approval · 2014-10-30FDA Approved: NICORETTE 4MG FRUIT CHILL GUM, LIL DRUG STORE — Supplemental Application (Lil' Drug Store Products, Inc.)
FDA approved a supplemental application for NICORETTE 4MG FRUIT CHILL GUM (nicotine polacrilex) from Lil' Drug Store Products, Inc.
-
CLINICAL_TRIALS trial_result · 2014-10-30Clinical Trial Update: Physiological Responses in Tobacco Chippers
A completed clinical trial at Oregon Health and Science University studying physiological responses in smokers under stress.
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Effects of ABT-089 on Smoking Abstinence Symptoms and Reward [Phase 2]
Phase 2 trial evaluating ABT-089 on smoking abstinence symptoms and reward in tobacco use disorder. The study was terminated and results wer…
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: A Pilot Study to Evaluate the Efficacy of Ariva® Silver Wintergreen, a Smoking Aversive Lozenge [Phase 1]
A Phase 1 pilot study evaluating the efficacy of Ariva Silver Wintergreen, a smoking aversive lozenge, for tobacco use disorder and smoking …
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Pilot Study to Evaluate the Safety and Efficacy of Ariva® Silver Wintergreen in Reducing Cigarette Craving in Smokers [Phase 1]
A Phase 1 pilot trial evaluated the safety and preliminary efficacy of Ariva Silver Wintergreen in reducing cigarette craving among individu…
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: A Pilot Study to Evaluate the Efficacy and Safety of Ariva® Silver Wintergreen in Healthy Smokers [Phase 1]
Phase 1 pilot trial evaluating the efficacy and safety of Ariva Silver Wintergreen in healthy smokers has completed.
-
FDA approval · 2014-10-22FDA Approved: FOSTER AND THRIVE NICOTINE — Supplemental Application (Strategic Sourcing Services LLC)
FDA approved a supplemental application for Foster and Thrive Nicotine (nicotine polacrilex) by Strategic Sourcing Services LLC.
-
FDA approval · 2014-10-15FDA Approved: CHANTIX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Chantix (varenicline tartrate) from Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Varenicline and Nicotine Interactions in Humans (VA) [NA]
This clinical trial update reports the completion of a study examining interactions between varenicline and nicotine in humans, with results…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Internet-based Group Contingency Management to Promote Smoking Abstinence [NA]
A completed clinical trial evaluating an internet-based group contingency management approach to promote smoking abstinence.
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: Memory Reconsolidation Blockade as a Novel Intervention for Nicotine Dependence [Phase 3]
Phase 3 trial evaluating memory reconsolidation blockade as a novel intervention for nicotine dependence (smoking cessation). The study is c…
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate [Phase 2]
Phase 2 proof-of-concept study evaluating ganaxolone as a candidate for smoking cessation; study completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: Trial of Nicotine Nasal Spray as an Aid for Smoking Cessation in Schizophrenia [Phase 4]
Phase 4 trial evaluating nicotine nasal spray for smoking cessation in schizophrenia has completed. Results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-09-03Clinical Trial Update: Improving Varenicline Adherence and Outcomes in Homeless Smokers [Phase 3]
Phase 3 clinical trial update evaluating varenicline adherence and smoking cessation outcomes in homeless smokers; the study has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: A Study To Evaluate The Efficacy And Safety Of Varenicline Compared To Placebo For Smoking Cessation Through Reduction [Phase 4]
A Phase 4 trial comparing varenicline to placebo for smoking cessation via reduction, with results posted in 2014.
-
CLINICAL_TRIALS research · 2014-08-22Clinical Trial Update: Survey of Smokers Treated in the Emergency Department (ED) on Ownership and Usage of Cell Phones
A completed Yale University clinical trial surveyed smokers treated in the emergency department about ownership and usage of cell phones. It…
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Promoting Home Smoking Restrictions: Biomarker Feedback to Smoking and Non-Smoking Adults [NA]
A completed clinical trial evaluated whether providing biomarker feedback about smoking status to adults (smokers and non-smokers) can promo…
-
CLINICAL_TRIALS research · 2014-08-20Clinical Trial Update: Step-up to Quit: Using Low-to-moderate Intensity Exercise for Reducing Smoking Cue Reactivity Among Low-income Smokers [Phase 1]
Phase 1 clinical trial update on Step-up to Quit, testing whether low-to-moderate intensity exercise reduces smoking cue reactivity in low-i…